| Previous Close | 1.22 |
| Open | 1.24 |
| Bid | 0.95 x 1200 |
| Ask | 1.55 x 900 |
| Day's Range | 1.20 - 1.25 |
| 52 Week Range | 1.03 - 3.30 |
| Volume | 599,849 |
| Avg. Volume | 402,070 |
| Market Cap | 49.22M |
| Beta | -1.82 |
| PE Ratio (TTM) | -2.28 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Capital Cube•5 days ago
ETFs with exposure to pSivida Corp. : September 18, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Capital Cube•8 days agopSivida Corp. :PSDV-US: Earnings Analysis: 2017 By the Numbers : September 15, 2017
Categories: Yahoo FinanceGet free summary analysis pSivida Corp. reports financial results for the year ended June 30, 2017. We analyze the earnings along side the following peers of pSivida Corp. – Nektar Therapeutics, Regeneron Pharmaceuticals, Inc., Alimera Sciences, Inc., XOMA Corporation, Abbott Laboratories, Merck & Co., Inc., Heron Therapeutics Inc, Pfizer Inc. and Valeant Pharmaceuticals International Inc ... Read more (Read more...)
- Thomson Reuters StreetEvents•11 days ago
Edited Transcript of PSDV earnings conference call or presentation 11-Sep-17 8:30pm GMT
Q4 2017 pSivida Corp Earnings Call
